HIT Consultant May 21, 2024
Fred Pennic

What You Should Know:

WearLinq, a leader in wearable health monitoring, announced a strategic acquisition of AMI Cardiac Monitoring, LLC, a seasoned player in ambulatory cardiac monitoring.

– The acquisition, coupled with a recent $6.7M funding round, positions WearLinq to significantly expand access to their innovative eWave 6-lead ECG monitor and revolutionize the fight against atrial fibrillation (AFib), which recently received FDA 510(k) clearance.

Tackling the Silent Threat of AFib

AFib, a heart rhythm irregularity, affects one in three people in their lifetime. It increases stroke risk fivefold and often leads to heart failure. Yet, current diagnostic methods miss a significant portion of cases, with over 30% of patients receiving false negatives and needing retesting within...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Digital Health, Mergers & Acquisitions / JV, Technology, Trends, Wearables
'We can nip a pandemic in the bud with smartwatches'
Flattening the curve: How smartwatches could help stop a pandemic before it even begins
Unlocking the power of sensor data in type 2 diabetes care
Google’s Pixel Watch 3 Loss of Pulse Detection Feature Receives FDA Clearance
10 Ways Technology is Changing Healthcare - 3

Share This Article